ENAVATE SCIENCES
Enavate Sciences is committed to investing in and supporting the strategic growth of innovative therapeutic and enabling technology companies.
ENAVATE SCIENCES
Industry:
Health Care Life Science Medical
Founded:
2019-01-01
Status:
Active
Email Addresses:
[email protected]
Total Funding:
300 M USD
Current Advisors List
Current Employees Featured
Investors List
Patient Square Capital
Patient Square Capital investment in Private Equity Round - Enavate Sciences
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-07-20 | CAMP4 Therapeutics | Enavate Sciences investment in Series B - CAMP4 Therapeutics | 100 M USD |
Key Employee Changes
| Date | New article |
|---|---|
| 2022-07-11 | Enavate Sciences Appoints Industry Veteran Robert Glassman as Executive Vice President, Search & Evaluation |
More informations about "Enavate Sciences"
Enavate Sciences - Crunchbase Investor Profile
Enavate Sciences is committed to invest in and support the strategic growth of innovative therapeutic and enabling technology companies. New York, New York, United States; 1-10; Private Equity Firm Early Stage Venture, Late Stage …See details»
Patient Square Capital Announces the Formation of Enavate …
May 2, 2022 James Boylan, Accomplished Health Care Executive, Joins Enavate as CEO $300 Million Initial Investment Commitment Received. MENLO PARK, Calif., May 2, 2022 – Patient …See details»
Enavate Sciences - LinkedIn
Enavate Sciences is a platform dedicated to supporting therapeutic companies advancing medicines and enabling technologies with transformative potential to address patient need.See details»
Patient Square Capital Announces the Formation of Enavate …
May 2, 2022 Enavate Sciences will provide capital and strategic growth support to innovative companies to advance and accelerate the development of novel therapies with the intent to …See details»
Enavate Sciences launches with $300M to boost …
May 2, 2022 Enavate will provide guidance to life science companies to improve drug discovery and development, assist with clinical and market assessments and provide business development expertise.See details»
Enavate Sciences - Org Chart, Teams, Culture & Jobs - The Org
Enavate Sciences is committed to invest in and support the strategic growth of innovative therapeutic and enabling technology companies. Industries. Health Care. Headquarters. Menlo …See details»
Enavate Sciences - Products, Competitors, Financials, Employees ...
Enavate Sciences focuses on investing in and supporting innovative therapeutic and enabling technology companies within the life sciences sector. The company provides significant …See details»
Board of Directors - Enavate Sciences
Jim MomtazeeChairman of the Board of Directors, Enavate Sciences Managing Partner, Patient Square Capital. Read Bio. James Boylan Chief Executive Officer Board Member, Enavate …See details»
Enavate Sciences - Investments, Portfolio & Company Exits
Enavate Sciences 's most notable exits include Immunome, CAMP4 Therapeutics, and Upstream Bio. Which industries has this organization had the most exits in? Show . Immunome …See details»
A Brief History of Enavate Sciences – CBM
Oct 2, 2024 Enavate Sciences was founded in 2010 by a group of seasoned entrepreneurs and industry experts with a shared vision to revolutionize the healthcare and biotechnology …See details»
Enavate Sciences investment portfolio - PitchBook
Enavate Sciences General Information Company Description. Founded in 2022, Enavate Sciences is a private equity firm based in New York, New York. The firm seeks to invest in …See details»
Enavate Sciences - Funding, Financials, Valuation & Investors
Enavate Sciences is committed to invest in and support the strategic growth of innovative therapeutic and enabling technology companies. Search Crunchbase. ... How much funding …See details»
Enavate Sciences Hires Christine Del Corsano as Chief Financial …
Jan 16, 2024 Enavate Sciences, a portfolio company of Patient Square Capital, is pleased to announce that Christine Del Corsano has joined the firm as their Chief Financial Officer. Ms. …See details»
Mission, Vision & Core Values of Enavate Sciences – CBM
Enavate Sciences is dedicated to investing in and supporting the strategic growth of innovative therapeutic and enabling technology companies. Our mission is to drive advancements in the …See details»
Who Owns Enavate Sciences – CBM - canvasbusinessmodel.com
Decision-Making Processes: The ownership structure of Enavate Sciences can impact the decision-making processes within the organization. Owners who are actively involved in the …See details»
Patient Square Capital Announces the Formation of Enavate …
May 2, 2022 At Enavate Sciences, Mr. Boylan will assemble a select team of professionals to support Enavate’s various companies in key functions of “company building” in the life …See details»
Enavate Sciences - Contacts, Employees, Board Members
Enavate Sciences has 4 current employee profiles, including Executive Vice President, Commercialization Edd Fleming. Enavate Sciences has 1 board member or advisor, James …See details»
Scientist Dana Devine helped modernize transfusion practices in …
6 hours ago In 2004, the organization made the decision to transition to the buffy coat method. “This change was really driven by Dana’s scientific expertise and her passion,” says Graham …See details»
Team - Enavate Sciences
You acknowledge that the content of the Site is for general, informational purposes only and is not intended to constitute an offer to sell or buy any securities or other assets or promise to …See details»
Series B - Zenas BioPharma - 2022-11-07 - Crunchbase
Nov 7, 2022 Organization Name . Zenas BioPharma . Announced Date Nov 7, 2022; Funding Type Series B; Funding Stage Early Stage Venture; Money Raised . $118M. Lead Investors. …See details»